Holen Sie sich die Stockscreener-App
75.35
2.67%
1.9605
Schlusskurs vom Vortag:
$73.39
Offen:
$72.1
24-Stunden-Volumen:
475.80K
Relative Volume:
0.39
Marktkapitalisierung:
$10.09B
Einnahmen:
$2.48B
Nettoeinkommen (Verlust:
$91.51M
KGV:
112.46
EPS:
0.67
Netto-Cashflow:
$293.77M
1W Leistung:
+1.34%
1M Leistung:
-6.19%
6M Leistung:
+7.67%
1J Leistung:
+45.40%
1-Tages-Spanne:
$71.73
$75.56
1-Wochen-Bereich:
$70.67
$75.56
52-Wochen-Spanne:
$49.33
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
75.25 | 10.09B | 2.48B | 91.51M | 293.77M | 0.67 |
|
ABT
Abbott Laboratories
|
131.70 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.76 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
375.31 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.69 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.11 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Robotic-assisted Surgery Systems Market Set to Witness - openPR.com
Total Disc Replacement Market Future Business Opportunities - openPR.com
Levi & Korsinsky Reminds Shareholders of an Investigation into Globus Medical, Inc. (GMED) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
Despite the downward trend in earnings at Globus Medical (NYSE:GMED) the stock grows 7.0%, bringing five-year gains to 80% - Yahoo Finance
Orthobiologics Market Future Business Opportunities - openPR
New Product Launches Benefit GMED Stock Amid Macro Issues - MSN
1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down - Yahoo Finance
GMED Stock Jumps 41.8% in a Year: What's Behind the Rally? - Yahoo Finance
Globus Medical (NYSE:GMED) shareholders notch a 11% CAGR over 5 years, yet earnings have been shrinking - simplywall.st
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec – Ortho Spine News - OrthoSpineNews
How Is The Market Feeling About Globus Medical? - Benzinga
Should You Hold Globus Medical Stock in Your Portfolio Now? - MSN
Spinal Fusion Device Market Forecast Report and Company - GlobeNewswire
Truist Financial Has Lowered Expectations for Globus Medical (NYSE:GMED) Stock Price - MarketBeat
Breaking Down Globus Medical: 5 Analysts Share Their Views - Benzinga
Stifel maintains Buy rating and $94 target on Globus Medical stock - Investing.com UK
Truist Cuts Price Target on Globus Medical to $82 From $90, Keeps Hold Rating -March 18, 2025 at 07:08 am EDT - MarketScreener
Interspinous Spacers Market Growth in Future Scope 2025-2032 | - openPR
Piper Sandler Sticks to Their Buy Rating for Globus Medical (GMED) - The Globe and Mail
Global Medical Handily Beats 2024 Sales Estimates - Orthopedics This Week
Globus Medical Expands Anterior Spine Portfolio With Two New Offerings - Yahoo Finance
Globus Medical Introduces Advanced Solutions for ALIF Surgery - MyChesCo
Globus Medical (NYSE:GMED) Stock Rating Upgraded by StockNews.com - Defense World
Globus Medical introduces new spine surgery solutions By Investing.com - Investing.com Canada
Globus Medical introduces new spine surgery solutions - Investing.com
Globus Medical Launches Innovative COHERE™ ALIF Spacer and Modulus™ ALIF Blades for Spine Surgery - Nasdaq
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio - Bluefield Daily Telegraph
Globus Medical extends versatility of Advanced Materials - GlobeNewswire
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades - Yahoo Finance
Hip Replacement Market Report and Company Analysis 2025-2033 Featuring Smith & Nephew, J&J, Integra, Zimmer Biomet, Stryker, B. Braun Melsungen, Globus Medical, MicroPort Scientific, Conformis - OrthoSpineNews
OsteoCentric Technologies Enters into a Non-Exclusive Licensing Agreement with Globus Medical - The Malaysian Reserve
Implantable Medical Devices Market growing at a CAGR of 7.2% from 2021 to 2030 | CONMED Corporation, Globus - EIN News
Hip Replacement Market Report and Company Analysis - GlobeNewswire
Medical Devices & SuppliesSpecialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers - Yahoo Finance
Globus Medical to Showcase Cutting-Edge Innovations at 2025 AAOS Meeting - MSN
Proficio Capital Partners LLC Buys Shares of 14,392 Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Medical to feature ExcelsiusFlex™ for Total Knee - GlobeNewswire
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting - The Manila Times
Globus Medical to Showcase Innovative Technologies at 2025 AAOS Annual Meeting in San Diego - Nasdaq
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of ... - Bluefield Daily Telegraph
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic - EIN News
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference - GlobeNewswire
Can Globus Medical's Conference Presentation Reveal New Growth Strategy? - StockTitan
Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock? - MSN
There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings - Simply Wall St
Globus Medical's (NYSE:GMED) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
Private Advisor Group LLC Boosts Stake in Globus Medical, Inc. (NYSE:GMED) - Defense World
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):